Denis A. Mogilenko

3.1k total citations · 2 hit papers
33 papers, 1.4k citations indexed

About

Denis A. Mogilenko is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Denis A. Mogilenko has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Denis A. Mogilenko's work include Peroxisome Proliferator-Activated Receptors (12 papers), Cancer, Lipids, and Metabolism (6 papers) and Cholesterol and Lipid Metabolism (6 papers). Denis A. Mogilenko is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (12 papers), Cancer, Lipids, and Metabolism (6 papers) and Cholesterol and Lipid Metabolism (6 papers). Denis A. Mogilenko collaborates with scholars based in Russia, United States and France. Denis A. Mogilenko's co-authors include Maxim N. Artyomov, Irina Shchukina, Sergey Orlov, Vladimir S. Shavva, Dizhe Eb, Perevozchikov Ap, Anwesha Laha, Samantha Burdess, Laura Arthur and Amanda Swain and has published in prestigious journals such as Journal of Biological Chemistry, Immunity and Nature reviews. Immunology.

In The Last Decade

Denis A. Mogilenko

32 papers receiving 1.3k citations

Hit Papers

Comprehensive Profiling of an Aging Immune System Reveals... 2020 2026 2022 2024 2020 2021 100 200 300

Peers

Denis A. Mogilenko
Erwin Wijnands Netherlands
Cody J. Diehl United States
Ekaterina K. Koltsova United States
Akshaya K. Meher United States
Jong Sung Park South Korea
Erwin Wijnands Netherlands
Denis A. Mogilenko
Citations per year, relative to Denis A. Mogilenko Denis A. Mogilenko (= 1×) peers Erwin Wijnands

Countries citing papers authored by Denis A. Mogilenko

Since Specialization
Citations

This map shows the geographic impact of Denis A. Mogilenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis A. Mogilenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis A. Mogilenko more than expected).

Fields of papers citing papers by Denis A. Mogilenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis A. Mogilenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis A. Mogilenko. The network helps show where Denis A. Mogilenko may publish in the future.

Co-authorship network of co-authors of Denis A. Mogilenko

This figure shows the co-authorship network connecting the top 25 collaborators of Denis A. Mogilenko. A scholar is included among the top collaborators of Denis A. Mogilenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis A. Mogilenko. Denis A. Mogilenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arner, Emily N., et al.. (2024). Immunometabolism of ferroptosis in the tumor microenvironment. Frontiers in Oncology. 14. 1441338–1441338. 6 indexed citations
2.
Terekhova, Marina, Amanda Swain, Pavla Boháčová, et al.. (2023). Single-cell atlas of healthy human blood unveils age-related loss of NKG2C+GZMB−CD8+ memory T cells and accumulation of type 2 memory T cells. Immunity. 56(12). 2836–2854.e9. 61 indexed citations
3.
Dehondt, Hélène, Arianna Marino, Laura Butruille, et al.. (2023). Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis. Molecular Metabolism. 69. 101686–101686. 16 indexed citations
4.
Shavva, Vladimir S., et al.. (2022). Adiponectin Stimulates Apolipoprotein A-1 Gene Expression in HepG2 Cells via AMPK, PPARα, and LXRs Signaling Mechanisms. Biochemistry (Moscow). 87(11). 1252–1259. 6 indexed citations
5.
Arthur, Laura, Ekaterina Esaulova, Denis A. Mogilenko, et al.. (2021). Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging. Nature Aging. 1(6). 535–549. 30 indexed citations
6.
Mogilenko, Denis A., Robert Caïazzo, Laurent L’homme, et al.. (2021). IFNγ-producing NK cells in adipose tissue are associated with hyperglycemia and insulin resistance in obese women. International Journal of Obesity. 45(7). 1607–1617. 10 indexed citations
7.
Mogilenko, Denis A., Irina Shchukina, & Maxim N. Artyomov. (2021). Immune ageing at single-cell resolution. Nature reviews. Immunology. 22(8). 484–498. 214 indexed citations breakdown →
8.
Mogilenko, Denis A., Oleg Shpynov, Prabhakar S. Andhey, et al.. (2020). Comprehensive Profiling of an Aging Immune System Reveals Clonal GZMK+ CD8+ T Cells as Conserved Hallmark of Inflammaging. Immunity. 54(1). 99–115.e12. 348 indexed citations breakdown →
9.
Sebti, Yasmine, Lise Ferri, Denis A. Mogilenko, et al.. (2019). The LPS/D-Galactosamine-Induced Fulminant Hepatitis Model to Assess the Role of Ligand-Activated Nuclear Receptors on the NLRP3 Inflammasome Pathway In Vivo. Methods in molecular biology. 1951. 189–207. 7 indexed citations
10.
Mogilenko, Denis A., Vladimir S. Shavva, Dizhe Eb, & Sergey Orlov. (2019). Характеристика альтернативных промоторов гена аполипопротеина A-I человека. Молекулярная биология. 53(3). 485–496. 3 indexed citations
11.
Devos, Michaël, Denis A. Mogilenko, Sébastien Fleury, et al.. (2018). Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis. Journal of Investigative Dermatology. 139(1). 135–145. 44 indexed citations
13.
Mogilenko, Denis A., Sébastien Fleury, Gilles Doumont, et al.. (2017). Tristetraprolin expression by keratinocytes controls local and systemic inflammation. JCI Insight. 2(11). 40 indexed citations
14.
Shavva, Vladimir S., et al.. (2016). PPARγ Represses Apolipoprotein A‐I Gene but Impedes TNFα‐Mediated ApoA‐I Downregulation in HepG2 Cells. Journal of Cellular Biochemistry. 117(9). 2010–2022. 14 indexed citations
16.
Mogilenko, Denis A., Andrey S. Trulioff, Vladimir S. Shavva, et al.. (2011). Modified Low Density Lipoprotein Stimulates Complement C3 Expression and Secretion via Liver X Receptor and Toll-like Receptor 4 Activation in Human Macrophages. Journal of Biological Chemistry. 287(8). 5954–5968. 52 indexed citations
17.
Mogilenko, Denis A., Vladimir S. Shavva, Dizhe Eb, Sergey Orlov, & Perevozchikov Ap. (2010). PPARγ activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells. Biochemical and Biophysical Research Communications. 402(3). 477–482. 34 indexed citations
18.
Orlov, Sergey, et al.. (2010). Effect of TNFα on activities of different promoters of human apolipoprotein A-I gene. Biochemical and Biophysical Research Communications. 398(2). 224–230. 18 indexed citations
19.
Mogilenko, Denis A., et al.. (2010). Expression of the starfish complement component C3 gene homolog under the influence of bacterial lipopolysaccharide. Molecular Biology. 44(1). 67–76. 7 indexed citations
20.
Mogilenko, Denis A., et al.. (2008). Ap1-like Cis elements in the 5′-regulatory region of the human apolipoprotein A-I gene. Molecular Biology. 42(2). 261–269. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026